Li Kemin, Yin Rutie
From the Department of Gynaecology, West China Second University Hospital (KL, RY), Sichuan University, Chengdu, Sichuan, China.
Medicine (Baltimore). 2015 Feb;94(5):e435. doi: 10.1097/MD.0000000000000435.
The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with preinvasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity using ASCUS+ or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities using ASCUS+ or LSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity using ASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity using ASCUS+ or LSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, or HSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
本研究的目的是确定人乳头瘤病毒(HPV)检测在筛查宫颈浸润前病变患者中的价值。734名在常规筛查中被诊断为意义不明确的非典型鳞状细胞(ASCUS+)宫颈细胞学的女性,在诊断后的6个月内进行了额外的细胞学检测和HPV DNA检测,之后所有检测呈阳性的女性均被转诊进行阴道镜检查和活检。然后将检测结果用于确定HPV在诊断宫颈浸润前病变中的筛查价值。通过传统细胞学对细胞学和HPV检测进行比较。以ASCUS+或低级别鳞状上皮内瘤变(LSIL+)作为检测宫颈上皮内瘤变(CIN)II+的临界值时,敏感性的比值比(OR)分别为0.78(0.72,0.85)和0.82(0.70,0.95)(P<0.01)。以ASCUS+或LSIL+作为临界值时,分流细胞学和传统细胞学的敏感性不同(P<0.01)。以ASCUS+、LSIL+或高级别鳞状上皮内瘤变(HSIL+)作为临界值时,细胞学或HPV检测与传统细胞学在敏感性上存在差异(P<0.01)。还将细胞学和HPV检测与传统细胞学进行了比较。以ASCUS+或LSIL+作为检测CIN II+的临界值时,特异性的OR分别为1.97(1.68,2.31)和1.10(1.02,1.18)(P<0.01)。以ASCUS+或LSIL+作为临界值时,分流细胞学和传统细胞学在特异性上存在差异(P<0.01)。最后,以ASCUS+、LSIL+或HSIL+作为临界值时,细胞学或HPV检测与传统细胞学在特异性上存在差异(P<0.01)。细胞学、HPV检测和分流细胞学提高了检测CIN II+的特异性,但未提高敏感性。此外,细胞学或HPV检测提高了检测CIN II+的敏感性,但未提高特异性。